A PHASE II STUDY OF ETANERCEPT (ENBREL), A TUMOUR NECROSIS FACTOR-ALPHA INHIBITOR IN RECURRENT OVARIAN CANCER

S. Madhusudan; S. R. Muthuramalingam; J. Braybrooke; S. Wilner; K. Kaur; C. Han; S. Hoare; F. Balkwill; T. S. Ganesan

doi:10.1136/ijgc-00009577-200409001-00213

Article info

Abstract

Posters October 4

A PHASE II STUDY OF ETANERCEPT (ENBREL), A TUMOUR NECROSIS FACTOR-ALPHA INHIBITOR IN RECURRENT OVARIAN CANCER

Authors

S. Madhusudan Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford, UK PubMed articles Google scholar articles
S. R. Muthuramalingam Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford, UK PubMed articles Google scholar articles
J. Braybrooke Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford, UK PubMed articles Google scholar articles
S. Wilner Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford, UK PubMed articles Google scholar articles
K. Kaur Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford, UK PubMed articles Google scholar articles
C. Han Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford, UK PubMed articles Google scholar articles
S. Hoare Cancer Research UK Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Science Building, Charterhouse Square, London, UK PubMed articles Google scholar articles
F. Balkwill Cancer Research UK Translational Oncology Laboratory, Barts and The London, Queen Mary's School of Medicine and Dentistry, Science Building, Charterhouse Square, London, UK PubMed articles Google scholar articles
T. S. Ganesan Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford, UK PubMed articles Google scholar articles

Citation

Madhusudan S, Muthuramalingam SR, Braybrooke J, et al

A PHASE II STUDY OF ETANERCEPT (ENBREL), A TUMOUR NECROSIS FACTOR-ALPHA INHIBITOR IN RECURRENT OVARIAN CANCER

International Journal of Gynecologic Cancer 2004;14:61-62.

Online issue publication

December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password